Synovel Sciences Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

Synovel Sciences General Information

Description

Developer of cancer eliminating drugs intended to offer cost effective alternatives to fulfill medical needs. The company's drugs are directed to eliminate cancer cells by specific modulation of immune checkpoint receptors.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Taipei
  • Taiwan
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Taipei
  • Taiwan

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Synovel Sciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 01-Mar-2017 Completed Generating Revenue
1. Early Stage VC 01-Jan-2015 Completed Startup
To view Synovel Sciences’s complete valuation and funding history, request access »

Synovel Sciences Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Diamond Biofund Venture Capital Minority
To view Synovel Sciences’s complete investors history, request access »

Synovel Sciences FAQs

  • When was Synovel Sciences founded?

    Synovel Sciences was founded in 2014.

  • Where is Synovel Sciences headquartered?

    Synovel Sciences is headquartered in Taipei, Taiwan.

  • What industry is Synovel Sciences in?

    Synovel Sciences’s primary industry is Drug Discovery.

  • Is Synovel Sciences a private or public company?

    Synovel Sciences is a Private company.

  • What is Synovel Sciences’s current revenue?

    The current revenue for Synovel Sciences is .

  • How much funding has Synovel Sciences raised over time?

    Synovel Sciences has raised $46.9M.

  • Who are Synovel Sciences’s investors?

    Diamond Biofund has invested in Synovel Sciences.

  • When was Synovel Sciences acquired?

    Synovel Sciences was acquired on 01-Mar-2017.

  • Who acquired Synovel Sciences?

    Synovel Sciences was acquired by Fountain Biopharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process